These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

815 related articles for article (PubMed ID: 21312346)

  • 1. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity.
    Aggarwal R; Sequeira W; Kokebie R; Mikolaitis RA; Fogg L; Finnegan A; Plaas A; Block JA; Jolly M
    Arthritis Care Res (Hoboken); 2011 Jun; 63(6):891-8. PubMed ID: 21312346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum free light chains, interferon-alpha, and interleukins in systemic lupus erythematosus.
    Jolly M; Francis S; Aggarwal R; Mikolaitis RA; Niewold TB; Chubinskaya S; Block JA; Scanzello C; Sequeira W
    Lupus; 2014 Aug; 23(9):881-8. PubMed ID: 24786785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus.
    Petri M; Stohl W; Chatham W; McCune WJ; Chevrier M; Ryel J; Recta V; Zhong J; Freimuth W
    Arthritis Rheum; 2008 Aug; 58(8):2453-9. PubMed ID: 18668552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Concentrations of Serum Immunoglobulin Free Light Chains in Systemic Lupus Erythematosus Patients in Relation to Disease Activity, Inflammatory Status, B Cell Activity and Epstein-Barr Virus Antibodies.
    Draborg AH; Lydolph MC; Westergaard M; Olesen Larsen S; Nielsen CT; Duus K; Jacobsen S; Houen G
    PLoS One; 2015; 10(9):e0138753. PubMed ID: 26402865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA; El-Gendi HI; Ahmed HH
    Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
    Hepburn AL; Mason JC; Davies KA
    Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum free light chains for monitoring systemic lupus erythematosus activity].
    Żychowska I; Suszek D; Dryglewska M; Nurzyńska D; Donica H; Majdan M
    Wiad Lek; 2018; 71(1 pt 1):21-31. PubMed ID: 29558348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus.
    Morgan PE; Sturgess AD; Davies MJ
    Arthritis Rheum; 2005 Jul; 52(7):2069-79. PubMed ID: 15986354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raised serum level of APRIL in patients with systemic lupus erythematosus: correlations with disease activity indices.
    Hegazy M; Darwish H; Darweesh H; El-Shehaby A; Emad Y
    Clin Immunol; 2010 Apr; 135(1):118-24. PubMed ID: 20116334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody clustering helps refine lupus prognosis.
    Kessel A; Rosner I; Halasz K; Grushko G; Shoenfeld Y; Paran D; Toubi E
    Semin Arthritis Rheum; 2009 Aug; 39(1):66-70. PubMed ID: 18538829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of erythrocyte-bound C4d as a biomarker to predict disease activity in patients with systemic lupus erythematosus.
    Yang DH; Chang DM; Lai JH; Lin FH; Chen CH
    Rheumatology (Oxford); 2009 Sep; 48(9):1083-7. PubMed ID: 19553377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
    Szekanecz E; Szucs G; Szekanecz Z; Tarr T; Antal-Szalmás P; Szamosi S; Szántó J; Kiss E
    J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum albumin as a marker for disease activity in patients with systemic lupus erythematosus.
    Yip J; Aghdassi E; Su J; Lou W; Reich H; Bargman J; Scholey J; Gladman DD; Urowitz MB; Fortin PR
    J Rheumatol; 2010 Aug; 37(8):1667-72. PubMed ID: 20516026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperprolactinemia in males with systemic lupus erythematosus.
    Mok CC; Lau CS; Lee KW; Wong RW
    J Rheumatol; 1998 Dec; 25(12):2357-63. PubMed ID: 9858430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phagocyte-specific S100A8/A9 protein levels during disease exacerbations and infections in systemic lupus erythematosus.
    Soyfoo MS; Roth J; Vogl T; Pochet R; Decaux G
    J Rheumatol; 2009 Oct; 36(10):2190-4. PubMed ID: 19755614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Feng X; Wu H; Grossman JM; Hanvivadhanakul P; FitzGerald JD; Park GS; Dong X; Chen W; Kim MH; Weng HH; Furst DE; Gorn A; McMahon M; Taylor M; Brahn E; Hahn BH; Tsao BP
    Arthritis Rheum; 2006 Sep; 54(9):2951-62. PubMed ID: 16947629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raised serum APRIL levels in patients with systemic lupus erythematosus.
    Koyama T; Tsukamoto H; Miyagi Y; Himeji D; Otsuka J; Miyagawa H; Harada M; Horiuchi T
    Ann Rheum Dis; 2005 Jul; 64(7):1065-7. PubMed ID: 15576416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
    Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
    Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reticulocytes bearing C4d as biomarkers of disease activity for systemic lupus erythematosus.
    Liu CC; Manzi S; Kao AH; Navratil JS; Ruffing MJ; Ahearn JM
    Arthritis Rheum; 2005 Oct; 52(10):3087-99. PubMed ID: 16200588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.